Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Arthur Kirsch | M | 72 | 12 years | |
| Peter J. Wise | M | 89 | - | |
| Kenneth Lee | M | 76 | 14 years | |
| James Joseph Mauzey | M | 75 | 6 years | |
| Alf Gunnar Martin Nicklasson | M | 69 | 3 years | |
| Jacques F. Réjeange | M | 83 | 14 years | |
| Neal Fowler | M | 62 | 6 years | |
| Seth A. Rudnick | M | 75 | 5 years | |
| Gilda Marie Thomas | F | 69 | 8 years | |
| John G. Fort | M | 69 | - | |
| Everardus Orlemans | M | 67 | 5 years | |
| William L. Hodges | M | 69 | 12 years | |
| Adrian Adams | M | 73 | 1 years | |
| Elizabeth Cermak | F | 66 | 4 years | |
| Anthony A. McKinney | M | 62 |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 6 years |
| Donald H. Namm | M | - | - | |
| W. Clint Burrus | M | - | - | |
| William James Alexander | M | 74 | - | |
| Joseph J Ruvane | M | - | - | |
| Robert J. Cruikshank | M | 93 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 15 years |
| Angela Larson | F | - | 3 years | |
| Andrew Koven | M | 66 | 1 years | |
| Bruce A. Tomason | M | 76 | 11 years | |
| Andrew L. Finn | M | 75 | 3 years | |
| Matthew E. Czajkowski | M | 73 | 4 years | |
| Kristina M. Adomonis | F | 69 | 8 years | |
| James R. Butler | M | - | - | |
| Ted G. Wood | M | 86 | 6 years | |
| Paul J. Rizzo | M | 96 | 8 years | |
| James A. Thomson | M | 79 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 14 years |
| Tomás S. Bocanegra | M | 75 | 1 years | |
| Marshall E. Reese | M | 78 | 5 years | |
| Dennis L. McNamara | M | 58 | 17 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 33 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John R. Plachetka
- Personal Network
